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Cytidine Deamination of Retroviral DNA
by Diverse APOBEC Proteins
APOBEC3G is one member of the mammalian cytidine
deaminase family, of which eight others appear to be
expressed in humans [15].
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1Department of Infectious Diseases To investigate the capacity of diverse APOBEC pro-
teins to regulate retroviral infection, we first tested theirGuy’s, King’s and St Thomas’ School of Medicine
King’s College London effects on HIV. Wild-type or vif-deficient (vif) HIV were
produced in the presence of either human APOBEC3GLondon, SE1 9RT
United Kingdom (hA3G), one of six other human APOBECs, murine APO-
BEC3 (mA3), rat APOBEC1 (rA1), or a control vector and2 Department of Medicine
Washington University Medical School used in single-cycle challenges of C8166-CCR5/HIV-
CAT indicator cells for evaluating relative infectivity (Fig-St. Louis, Missouri 63110
ure 1A). hA3G had a dramatic inhibitory effect on the
vif virus but only a mild (less than 2-fold) effect on its
wild-type counterpart [4]. Among the other samples,Summary
mA3 [3] and rA1 each had strong inhibitory phenotypes
that were not suppressed by Vif, human APOBEC3BThe human cytidine deaminase APOBEC3G edits both
(hA3B) had a less pronounced effect but was also Vifnascent human immunodeficiency virus (HIV) and mu-
resistant, and human APOBEC3F (hA3F) yielded a Vif-rine leukemia virus (MLV) reverse transcripts, resulting
sensitive phenotype that, though not quite as dramatic,in loss of infectivity [1–5]. The HIV Vif protein is able
resembled that seen for hA3G. We note that two groupsto protect both viruses from this innate restriction to
have recently reported similar findings for hA3F [16, 17].infection. Here, we demonstrate that a number of other
It is noteworthy that all APOBECs with anti-HIV activ-APOBEC family members from both humans and ro-
ity, except rA1, have two potential enzymatic sites [15]dents can mediate anti-HIV effects, through cytidine
and that the three human proteins, hA3G, hA3B, anddeamination. Three of these, rat APOBEC1, mouse
hA3F, share at least 50% amino acid sequence identity.APOBEC3, and human APOBEC3B, are able to inhibit
The aspartic acid residue at position 128 of hA3G hasHIV infectivity even in the presence of Vif. Like APO-
been shown to be critical for sensitivity to Vif [18–21];BEC3G, human APOBEC3F preferentially restricts vif-
the equivalent residue in both hA3B and hA3F is glutamicdeficient virus. Indeed, the mutation spectra and ex-
acid, implying that this individual position is unlikely topression profile found for APOBEC3F indicate that this
account for the resistance of hA3B to Vif seen here.enzyme, together with APOBEC3G, accounts for the
Because at least three of the proteins that appearedG to A hypermutation of proviruses described in HIV-
not to affect HIV, hA1, hAID, and hA3C, are functionallyinfected individuals [6–8]. Surprisingly, although MLV
active in other systems [22–25], and all proteins areinfectivity is acutely reduced by APOBEC3G, no other
expressed when epitope-tagged (Figure S1 in the Sup-family member tested here had this effect. It is espe-
plemental Data available with this article online), the lackcially interesting that although both rodent APOBECs
of anti-HIV activity could be attributable to an intrinsicmarkedly diminish wild-type HIV infectivity, MLV is re-
inability to influence HIV infection or to the absence ofsistant to these proteins. This implies that MLV may
important cellular cofactors from 293T cells [26].have evolved to avoid deamination by mouse APO-
In addition to inhibiting the infectivity of HIV and otherBEC3. Overall, our findings show that although APO-
lentiviruses, hA3G has also been shown to be a potentBEC family members are highly related, they exhibit
suppressor of infection by murine leukemia virus (MLV)significantly distinct antiviral characteristics that may
[1, 2]. To explore the breadth of retroviral restrictionprovide new insights into host-pathogen interactions.
exhibited by other APOBECs, we tested the infectivity
of recombinant MLV made in the presence of each family
Results and Discussion member. With the exception of hA3G, we did not detect
any significant inhibition of MLV with any of the APOBEC
The apolipoprotein B mRNA-editing enzyme, catalytic family members, including the rodent proteins mA3 and
polypeptide-like 3G (APOBEC3G) protein is a potent in- rA1 (Figure 1B). It is interesting to note the differing
hibitor of infection for a wide range of retroviruses [1,5]. effects on HIV and MLV of hA3B and hA3F, compared
The enzyme mediates the lethal deamination of cytosine to the more broadly acting hA3G. Moreover, since mA3
(C) to uracil (U) in nascent (mostly) minus-strand viral is active on HIV substrates and also closely resembles
cDNAs [1–3, 5, 9] leading to debilitating levels of hyper- hA3G (30% amino acid sequence identity), we propose
mutation (guanine [G] to adenine [A] on the plus strand). that MLV may have evolved an alternative mechanism
Under normal circumstances, the viral regulatory protein for evading cytosine deamination by cognate murine
Vif protects HIV infection from the inhibitory effects of APOBEC proteins.
APOBEC3G [2, 4, 5, 10] by inducing its proteasomal To assess whether, like hA3G [1–3, 5], the antiviral
degradation and exclusion from virus particles [11–14]. effects of the other APOBEC proteins are associated
with cytidine deamination, we recovered viral cDNAs
from infected cells and cloned and sequenced a 650 bp*Correspondence: michael.malim@kcl.ac.uk
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mA3 imparted substantial levels of mutagenesis. Finally,
and in keeping with the correlation between infection
inhibition and the mutational frequency, sequencing of
MLV reverse transcripts demonstrated that only hA3G
induced mutations in this system (data not shown).
The full spectra of base substitutions for these HIV
infections are presented in terms of plus-strand se-
quence in Figure S2 and are summarized in Table 1,
together with mutation frequencies. Consistent with ear-
lier work, hA3G induced mutations that were exclusively
G to A transitions [1, 2, 5]. Although this pattern was also
noted for hA3B-associated mutations, G to A transitions
were the only predominant mutation induced by hA3F
and mA3, with some C to T mutations detected. Thus,
the majority of APOBEC-induced mutations can be at-
tributed to C to U deamination of minus-strand reverse
transcripts.
Previous studies have demonstrated that the target
sites for APOBEC-mediated cytidine deamination are
not random and that local consensus sites for deamina-
tion can be discerned [1, 9, 23, 25, 27]. Figure 3A cata-
logs the frequencies with which each base was found
at the2,1, and1 positions relative to the substrate
C residue, with the consensus below. The consensus
substrate for hA3G has C at both of the two upstream
positions [1, 25]. The only other case in which C was
the preferred base in the 1 position was for mA3, and
even here the preference for C was less strong. In con-
trast, the preferred 1 base for hA3B and hA3F was T,
with a strong bias toward a pyrimidine at the2 position.
In sum, different APOBEC proteins display clear and
differing preferences for substrate cytosines in the con-
Figure 1. Diverse APOBEC Family Members Have Anti-HIV Activity
text of HIV DNA.
(A) Effects on HIV infectivity of APOBEC family members. Wild-type High levels of hA3G can impart a modest inhibition ofor vif-deficient (vif) HIV was produced in 293T cells transiently
wild-type HIV infection in vitro [2, 4]. Such escape fromtransfected with an APOBEC family member. Virus-containing su-
Vif-mediated inhibition may underlie the generationpernatants were used to challenge C8166-CCR5/HIV-CAT indicator
cells, and productive infection was measured as the induction of in vivo of G to A hypermutated proviruses (namely, in
CAT activity. Values are presented as percent infectivity relative to which up to 60% of G residues in certain regions can
virus produced in the absence of any APOBEC. Error bars represent be mutated) in some AIDS patients [6–8]. Analysis of
standard deviation. hypermutated proviruses reveals that two dinucleotide(B) Effects on MLV infectivity of APOBEC family members. 293T-
targets, GpG and GpA, are heavily favored for substitu-derived stocks of YFP-encoding MLV produced by cotransfection
tion [8, 27], these equating to CpC and TpC, respectively,with an APOBEC family member were used to challenge Mus dunni
fibroblasts. The number of infected cells was measured using FACS. on the minus strand (mutated residues underlined). Be-
Values are presented as percent infectivity relative to virus produced cause CpC is the preferred substrate for hA3G, whereas
in the absence of any APOBEC. Error bars represent standard devi- TpC is the preferred target for hA3B and hA3F, we con-
ation. sidered the possibility that hA3B and/or hA3F could
mediate APOBEC-mediated hypermutation in vivo. Ac-
nef/3LTR fragment. Figure 2 displays the percentage cordingly, we determined whether hA3B and hA3F are
of amplicons for each infection that contained any given expressed in human T cells, the predominant targets of
number of mutations. In general, there was good concor- natural HIV infection. Gene-specific RT-PCR assays were
dance between increasing mutational burden and the performed with RNA extracted from peripheral blood
loss of infectivity (Figure 1A). For example, half of the mononuclear cells (PBMCs) and several cell lines (Figure
hA3G/wild-type sequences were unaltered, whereas 3B). As seen in lane 6, expression of hA3F and hA3G
70% of the hA3G/vif samples harbored nine or more was readily detected in PBMCs, whereas expression of
mutations. Interestingly, one of the hA3G/wild-type se- hA3B was not. Expression of hA3F and hA3G was clearly
quences contained 11 mutations, illustrating that while detected in assorted HIV nonpermissive cell lines
Vif is an effective inhibitor of hA3G function, protection (HUT78, H9, and CEM, i.e., cells that restrict vif viral
can be far from absolute for a minor subset of viral replication [4, 28, 29]), whereas substantial hA3B ex-
particles. The modulation of hA3F by Vif was also easy pression was limited to CEM cells (lanes 7-9) [16]. In
to discern: 90% of the sequences had zero or one contrast, expression of all three genes was undetectable
mutation in the wild-type infection, but the number or very low in the HIV permissive lines, HeLa, SupT1,
dropped to50% in the absence of Vif. Consistent with and CEM-SS (lanes 3–5). Interestingly, the expression
profiles of hA3G and hA3F in human tissues were alsoits relatively potent Vif-resistant, anti-HIV phenotype,
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Figure 2. Comparison of the Extent of Muta-
tion of HIV by Different APOBEC Family
Members
Wild-type or vif HIV was produced in 293T
cells in the presence of individual APOBEC
family members, harvested, and used to chal-
lenge susceptible target cells. Reverse tran-
scribed HIV DNA was amplified from target
cells, cloned, and sequenced. The bar charts
depict the percent of HIV sequences carrying
the indicated number of mutations within the
650 bp interval sequenced, for each infection.
The total numbers of amplicons that were se-
quenced for each data set are indicated in
Table 1.
essentially indistinguishable, potentially indicative of lyze destructive editing of cytosine residues in the minus
strands of HIV reverse transcripts (Figures 2 and S2,coregulation (see related paper by Liddament et al. in
this issue [30]). Thus, we conclude that hA3G and hA3F and Table 1) and, consequently, to inhibit productive
infection (Figure 1). The likely physiological relevanceboth play a significant role in generating G to A mutations
in HIV sequences in vivo. Therefore, it is perhaps predict- of the data obtained with hA3F is underscored by the
comparison between this enzyme’s substrate prefer-able that hA3F function is also efficiently inhibited by
Vif (Figure 1A). ences (Figure 3) [16] and the patterns of G to A hyper-
mutation that have been documented in HIV infectedTo summarize our findings, we have demonstrated
that multiple APOBEC proteins have the ability to cata- individuals. Furthermore, even though the expression
Table 1. Summary of the Rates of HIV Mutation by Different APOBEC Family Members
No APOBEC hA3G hA3B hA3F mA3
WT Vif WT Vif WT Vif WT Vif WT Vif
Infectivity (%) 100 100 75 4 22 34 70 11 5 5
Total clones sequenced 10 10 10 10 51 29 51 50 10 7
Total base pairs sequenced 6,500 6,500 6,500 6,500 33,150 18,850 33,150 32,500 6,500 4,550
Total number of mutations 4 4 28 112 75 39 31 85 71 51
Total G to A mutations 0 1 25 105 60 27 11 59 69 37
Total C to T mutations 1 2 0 1 3 1 7 12 2 11
Average mutations/sequence 0.40 0.40 2.80 11.20 1.47 1.34 0.61 1.70 7.10 7.29
Average mutations/100bp 0.06 0.06 0.43 1.72 0.23 0.21 0.09 0.26 1.09 1.12
Average G to A mutations/100bp 0.00 0.02 0.38 1.62 0.18 0.14 0.03 0.18 1.06 0.81
Average C to T mutations/100bp 0.02 0.03 0.00 0.02 0.01 0.01 0.02 0.04 0.03 0.24
Wild type or vif HIV was produced in 293T cells transiently transfected with each APOBEC family member or empty vector. Viruses were
harvested and used to challenge susceptible target cells. Reverse transcribed viral DNA was then amplified from target cells, cloned, and
sequenced. The number and type of mutations were counted, and rates of mutation were calculated.
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Figure 3. Both hA3F and hA3G May Deami-
nate HIV cDNA In Vivo
(A) Comparison of the preferred sequence
context for dC deamination in HIV by different
APOBEC family members. Mutations in HIV
are assigned to the dC residue on the minus
(first)-strand cDNA (position zero). The fre-
quency (as a percentage) with which each of
the four bases is found at positions adjacent
to this dC are indicated, based on a compila-
tion of all the G to A coding-strand transitions
observed for each APOBEC. The consensus
sequence is shown at the bottom of each
minitable.
(B) hA3F and hA3G are expressed in HIV non-
permissive cells including human PBMCs.
Agarose gel showing the products of PCR
reactions with primers specific for hA3B,
hA3F, or hA3G. Template was either cDNA
from the indicated cell type, water as a nega-
tive control, or plasmid-expressing hA3B,
hA3F, or hA3G, respectively, as positive con-
trols.
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